Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Withholding vs Continuing SGLT2 Inhibitors in Patients Undergoing Coronary Angiography
TCTR20230703004Phase 3Unknown
- Sponsor
- Central Chest Institute of Thailand
- Start
- May 2023
- Countries
- 1
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Central Chest Institute of Thailand. Status: unknown.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20230703004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230703004.